Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis

Clinical trial NCT00035178 · COMPLETED

Trial details

NCT number: NCT00035178
Sponsor: Texas Biotechnology Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Failure, Chronic Renal Disease, End-Stage

Start date: 2002-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.